Contact Us

Science breakthrough

QTL mapping, a candidate gene conserved from fruit fly to human, and a correlation measured across roughly 600 human breast specimens.

Science breakthrough

One gene, five ways of looking at it

The whole programme, step by step, with the figures the company published. Nothing here is a rendering or an illustration — every image is from the paper itself.

Discovery

A susceptibility locus on rat chromosome 12

Rat strains differ dramatically in their susceptibility to mammary carcinogenesis. On the assumption that susceptibility genes are conserved across mammalian species and hence inform human carcinogenesis, the laboratory used a genetic backcross between the resistant Copenhagen (Cop) and susceptible Fischer 344 (F344) strains.

  • Mcs30 mapped to the centromeric region of rat chromosome 12
  • LOD score of approximately 8.6 at the D12Rat59 marker
  • A region of about 12 Mbp on the long arm of RNO12
  • Synteny conserved on human chromosome 13q12 to 13q13
  • QTL mapping
  • Mcs30
  • RNO12
  • LOD ~8.6
Interval mapping of putative quantitative trait loci on rat chromosome 12 that confer susceptibility to NMU-induced mammary carcinogenesis.
Interval mapping of putative quantitative trait loci on rat chromosome 12 that confer susceptibility to NMU-induced mammary carcinogenesis. From the company’s own paper, PLOS ONE, CC BY.

Figures

Every figure from the paper

Seven figures and five from the later study. Click any one to open it full size. Published in PLOS ONE and Frontiers in Oncology under a Creative Commons Attribution licence, which permits reuse with attribution.

Interval mapping of putative quantitative trait loci (QTL) on rat chromosomes 12 that confer susceptibility to NMU-induced mammary carcinogenesis.
Figure 1. Interval mapping of putative quantitative trait loci (QTL) on rat chromosomes 12 that confer susceptibility to NMU-induced mammary carcinogenesis.
FISH mapping of BAC CH230-85G15, containing D12RAT59, to rat chromosome 12q11-q12.
Figure 2. FISH mapping of BAC CH230-85G15, containing D12RAT59, to rat chromosome 12q11-q12.
Ideogram of rat chromosome 12 (RNO12).
Figure 3. Ideogram of rat chromosome 12 (RNO12).
Comparison of Brca2 mRNA levels in mammary tissue and DNA sequences in Cop and F344 rats.
Figure 4. Comparison of Brca2 mRNA levels in mammary tissue and DNA sequences in Cop and F344 rats.
Expression of rat Fry mRNA in rat tissues and mammary tumours.
Figure 5. Expression of rat Fry mRNA in rat tissues and mammary tumours.
Alignment of proteins encoded by FRY gene orthologs from different species.
Figure 6. Alignment of proteins encoded by FRY gene orthologs from different species.
FRY expression and/or function are reduced in breast cancer cell lines relative to the nontransformed MCF-10A human mammary epithelial cell line.
Figure 7. FRY expression and/or function are reduced in breast cancer cell lines relative to the nontransformed MCF-10A human mammary epithelial cell line.
Fry conditional knockout mice: body weight, general observations and behaviour.
Frontiers 2020, figure 1. Fry conditional knockout mice: body weight, general observations and behaviour.
Mammary gland whole mounts from Fry conditional knockout and control mice.
Frontiers 2020, figure 2. Mammary gland whole mounts from Fry conditional knockout and control mice.
Histology and gene expression in the mammary gland.
Frontiers 2020, figure 3. Histology and gene expression in the mammary gland.
Growth and morphology of breast cancer cells with altered Fry.
Frontiers 2020, figure 4. Growth and morphology of breast cancer cells with altered Fry.
Proliferation and signalling in Fry-deficient mammary tissue.
Frontiers 2020, figure 5. Proliferation and signalling in Fry-deficient mammary tissue.

Mechanism

How FRY is switched off

The laboratory’s hypothesis was that specific epigenetic and post-transcriptional mechanisms are responsible for the loss of FRY in tumour cells, and it set out to test them.

  • Epigenetic silencing by DNA methyltransferase enzymes
  • The long noncoding antisense transcript FRY-AS1 binding the FRY protein and altering its nuclear transport
  • Post-translational modification affecting nuclear localisation
  • LocusMcs30 / QTL30, RNO12
  • Interval~12 Mbp
  • Peak markerD12Rat59, LOD ~8.6
  • Human synteny13q12–13q13
  • GeneFRY, ortholog of furry
  • PatentPCT/US2011/063553
  • In one paragraph

    Why a rat QTL became a human biomarker

    Rat strains differ dramatically in their susceptibility to mammary carcinogenesis. On the assumption that susceptibility genes are conserved across mammalian species and hence inform human carcinogenesis, the laboratory mapped a susceptibility locus in a Copenhagen × Fischer 344 backcross, narrowed it to about 12 Mbp, and identified Fry within it.

    Fry turned out to inhibit tumourigenesis of human breast carcinoma cells by inducing differentiation and reversing epithelial–mesenchymal transition. In human tissue, reduced FRY mRNA and protein — especially nuclear protein — correlated strongly with aggressive histopathology, loss of hormone receptors and higher Elston grade, and with progression and metastasis in ovary, prostate and lung as well.

    That is the whole investment case: a mechanism that makes biological sense, a human correlation measured across hundreds of specimens, and a patent on using it.